176 related articles for article (PubMed ID: 20368187)
1. A call for sharing: adapting pharmaceutical research to new realities.
Munos BH; Chin WW
Sci Transl Med; 2009 Dec; 1(9):9cm8. PubMed ID: 20368187
[TBL] [Abstract][Full Text] [Related]
2. Open-access public-private partnerships to enable drug discovery--new approaches.
Müller S; Weigelt J
IDrugs; 2010 Mar; 13(3):175-80. PubMed ID: 20191434
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery: new models for industry-academic partnerships.
Tralau-Stewart CJ; Wyatt CA; Kleyn DE; Ayad A
Drug Discov Today; 2009 Jan; 14(1-2):95-101. PubMed ID: 18992364
[TBL] [Abstract][Full Text] [Related]
4. Strategic alliance management: lessons learned from the Bayer-Millennium collaboration.
Ziegelbauer K; Farquhar R
Drug Discov Today; 2004 Oct; 9(20):864-8. PubMed ID: 15475317
[No Abstract] [Full Text] [Related]
5. Drug discovery dilemma and Cura quartet collaboration.
Shah S; Federoff HJ
Drug Discov Today; 2009 Nov; 14(21-22):1006-10. PubMed ID: 19815089
[TBL] [Abstract][Full Text] [Related]
6. Racing to define pharmaceutical R&D external innovation models.
Wang L; Plump A; Ringel M
Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
[TBL] [Abstract][Full Text] [Related]
7. Fostering culture and optimizing organizational structure for implementing model-based drug development.
Zhang L; Allerheiligen SR; Lalonde RL; Stanski DR; Pfister M
J Clin Pharmacol; 2010 Sep; 50(9 Suppl):146S-150S. PubMed ID: 20881228
[TBL] [Abstract][Full Text] [Related]
8. Rebuilding the R&D engine in big pharma.
Garnier JP
Harv Bus Rev; 2008 May; 86(5):68-70, 72-6, 128. PubMed ID: 18543809
[TBL] [Abstract][Full Text] [Related]
9. Outcomes research collaborations between third-party payers, academia, and pharmaceutical manufacturers: What can we learn from clinical research?
Eichler HG; Kong SX; Grégoire JP
Eur J Health Econ; 2006 Jun; 7(2):129-35. PubMed ID: 16485122
[TBL] [Abstract][Full Text] [Related]
10. Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
Litten RZ; Ryan M; Falk D; Fertig J
Alcohol Clin Exp Res; 2014 May; 38(5):1196-9. PubMed ID: 24689461
[TBL] [Abstract][Full Text] [Related]
11. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
Rai AK; Reichman JH; Uhlir PF; Crossman C
Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
[No Abstract] [Full Text] [Related]
12. Funding medical and health-related research in the public interest.
Baird PA
CMAJ; 1996 Aug; 155(3):299-301. PubMed ID: 8705910
[TBL] [Abstract][Full Text] [Related]
13. University - industry collaborations: models, drivers and cultures.
Ehrismann D; Patel D
Swiss Med Wkly; 2015; 145():w14086. PubMed ID: 25658854
[TBL] [Abstract][Full Text] [Related]
14. [Collaboration with universities and innovate activity in the Spanish pharmaceutical industry (2003-2005)].
D'Este P; Tribó JA; García-Romero A
Med Clin (Barc); 2008 Dec; 131 Suppl 5():66-70. PubMed ID: 19631826
[TBL] [Abstract][Full Text] [Related]
15. Models for open innovation in the pharmaceutical industry.
Schuhmacher A; Germann PG; Trill H; Gassmann O
Drug Discov Today; 2013 Dec; 18(23-24):1133-7. PubMed ID: 23892183
[TBL] [Abstract][Full Text] [Related]
16. The pharmaceutical industry at risk: how excessive government regulation stifles innovation.
Epstein RA
Clin Pharmacol Ther; 2007 Aug; 82(2):131-2. PubMed ID: 17632536
[TBL] [Abstract][Full Text] [Related]
17. Effective executive management in the pharmaceutical industry.
Tran H; Kleiner BH
J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
[TBL] [Abstract][Full Text] [Related]
18. Outlook: finding improved medicines: the role of academic-industrial collaboration.
Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D
Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439
[TBL] [Abstract][Full Text] [Related]
19. Outsourcing chemical synthesis in the drug discovery process.
Festel G
Drug Discov Today; 2011 Mar; 16(5-6):237-43. PubMed ID: 21262378
[TBL] [Abstract][Full Text] [Related]
20. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
Shumoogam J; Al-Shamahi A
IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
